{"count": 2, "results": [{"_id": "18303938", "pmid": 18303938, "title": "Amlodipine/atorvastatin fixed-dose combination: a review of its use in the prevention of cardiovascular disease and in the treatment of hypertension and dyslipidemia.", "journal": "Am J Cardiovasc Drugs", "authors": ["McKeage K", "Siddiqui MA"], "date": "2008-01-01T00:00:00Z", "doi": "10.2165/00129784-200808010-00007", "meta_date_publication": "2008", "meta_volume": "8", "meta_issue": "1", "meta_pages": "51-67", "score": 50064.445, "text_hl": "@CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@Amlodipine@@@/@CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ fixed-dose combination: a review of its use in the prevention of @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular disease@@@ and in the treatment of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and @<m>DISEASE_Dyslipidemias</m> @DISEASE_MESH:D050171 @@@dyslipidemia@@@.", "citations": {"NLM": "McKeage K, Siddiqui MA. Amlodipine/atorvastatin fixed-dose combination: a review of its use in the prevention of cardiovascular disease and in the treatment of hypertension and dyslipidemia. Am J Cardiovasc Drugs. 2008;8(1):51-67. PMID: 18303938", "BibTeX": "@article{18303938, title={Amlodipine/atorvastatin fixed-dose combination: a review of its use in the prevention of cardiovascular disease and in the treatment of hypertension and dyslipidemia.}, author={McKeage K and Siddiqui MA}, journal={Am J Cardiovasc Drugs}, volume={8}, number={1}, pages={51-67}}"}}, {"_id": "15350169", "pmid": 15350169, "title": "Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease.", "journal": "Expert Rev Cardiovasc Ther", "authors": ["Frishman WH", "Zuckerman AL"], "date": "2004-09-01T00:00:00Z", "doi": "10.1586/14779072.2.5.675", "meta_date_publication": "2004 Sep", "meta_volume": "2", "meta_issue": "5", "meta_pages": "675-81", "score": 50059.19, "text_hl": "Combination therapy of @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine besylate@@@ (Norvasc, Pfizer Ltd) with @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin calcium@@@ (Lipitor, Pfizer Ltd), marketed as @<m>CHEMICAL_amlodipine_atorvastatin_drug_combination</m> @CHEMICAL_MESH:C487936 @@@Caduet@@@ (Pfizer Ltd) is the first dual-therapy compound designed to treat @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and/or @DISEASE_Angina_Pectoris @DISEASE_MESH:D000787 @@@angina@@@ and @<m>DISEASE_Dyslipidemias</m> @DISEASE_MESH:D050171 @@@dyslipidemia@@@ concurrently with a single daily pill in the full range of dosing combinations. ", "citations": {"NLM": "Frishman WH, Zuckerman AL. Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease. Expert Rev Cardiovasc Ther. 2004 Sep;2(5):675-81. PMID: 15350169", "BibTeX": "@article{15350169, title={Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease.}, author={Frishman WH and Zuckerman AL}, journal={Expert Rev Cardiovasc Ther}, volume={2}, number={5}, pages={675-81}}"}}]}